STOCK TITAN

Royalty Pharma officer proposes $1.72M share sale

Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Royalty Pharma plc (RPRX) officer Terrance Coyne reported a proposed sale of 34,791 common shares, with an aggregate market value of $1,723,546.14 and an approximate sale date of April 28, 2026. The shares are allocated as 32,916 by TPC RP 2021 LLC and 1,875 by TPC RP EPA1 LLC. The notice states that the sales are made in connection with a selling plan dated August 8, 2025, intended to comply with Rule 10b5-1(c).

Common shares proposed for sale 34,791 shares Approximate sale date April 28, 2026
Aggregate market value $1,723,546.14 Common shares proposed for sale
TPC RP 2021 LLC proposed sale 32,916 shares Allocation of the proposed sale
TPC RP EPA1 LLC proposed sale 1,875 shares Allocation of the proposed sale
Selling plan date August 8, 2025 Plan intended to comply with Rule 10b5-1(c)
Rule 10b5-1(c) regulatory
"intended to comply with Rule 10b5-1(c)"
Rule 10b5-1(c) is an SEC guideline that lets company insiders set up a written, pre-planned schedule to buy or sell their company stock when they are not in possession of material, nonpublic information. For investors, it matters because such plans can reduce the appearance of insider trading by separating decisions from inside knowledge—like putting your trades on autopilot—while also requiring scrutiny since pre-planned trades can still affect market confidence and share value.
selling plan financial
"made in connection with a selling plan dated 8/8/2025"
Performance Awards financial
"Acquired as compensation -- Performance Awards"
Aggregate Market Value financial
"Aggregate Market Value"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RPRX shares are proposed for sale?

The notice lists 34,791 common shares for sale, with an aggregate market value of $1,723,546.14 and an approximate sale date of April 28, 2026.

Was the proposed RPRX sale connected to a Rule 10b5-1 plan?

The sales are made in connection with a selling plan dated August 8, 2025, which is intended to comply with Rule 10b5-1(c).

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading